» Authors » Piero Giuseppe Meliante

Piero Giuseppe Meliante

Explore the profile of Piero Giuseppe Meliante including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 59
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Meliante P, Pizzolante S, Perna L, Filippi C, Bandiera G, Barbato C, et al.
Front Biosci (Landmark Ed) . 2025 Feb; 30(2):25267. PMID: 40018925
The accurate diagnosis of regional lymph node metastasis is critical for guiding treatment decisions in head and neck cancer patients. Despite advances in imaging techniques, detecting nodal metastasis using radiology...
2.
Costantino A, Sampieri C, Meliante P, De Virgilio A, Kim S
Oral Oncol . 2024 Feb; 150:106700. PMID: 38306755
No abstract available.
3.
Meliante P, Battilocchi L, Costantino A, Lee K, Moon S, Ralli M, et al.
Head Neck . 2024 Jan; 46(3):708-712. PMID: 38221740
Locally advanced laryngeal cancers treatment often involves total laryngectomy, which some patients are unwilling to undergo, even if this choice reduces their survival probability. Therefore, the objective of laryngeal oncologic...
4.
Meliante P, Petrella C, Fiore M, Minni A, Barbato C
Curr Issues Mol Biol . 2023 Nov; 45(11):9215-9233. PMID: 37998754
The treatment of unresectable or metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) has traditionally relied on chemotherapy or radiotherapy, yielding suboptimal outcomes. The introduction of immunotherapy has significantly improved...
5.
Costantino A, Sampieri C, Meliante P, De Virgilio A, Kim S
Oral Oncol . 2023 Nov; 148:106629. PMID: 37972462
Background: The recently developed da Vinci single-port (SP) system offers potential advantages in maneuverability within narrower surgical spaces. This study aims to compare intra- and post-operative outcomes, technical advantages, and...
6.
Meliante P, Petrella C, Fiore M, Minni A, Barbato C
Antioxidants (Basel) . 2023 Sep; 12(9). PMID: 37760056
Approximately 5-20% of HNSCC patients experience second primary cancers within the first 5 years of treatment, contributing to high mortality rates. Epidemiological evidence has linked a low dietary intake of...
7.
Meliante P, Colizza A, Ralli M, Minni A, Angeletti D, Cambria F, et al.
Acta Otorhinolaryngol Ital . 2023 Sep; 43(Suppl 1):S76-S83. PMID: 37698104
No abstract available.
8.
Mastino P, Rosati D, de Soccio G, Romeo M, Pentangelo D, Venarubea S, et al.
Antioxidants (Basel) . 2023 Jul; 12(7). PMID: 37507968
Introduction: OSAS is a disease that affects 2% of men and 4% of women of middle age. It is a major health public problem because untreated OSAS could lead to...
9.
Costantino A, Meliante P, Sampieri C, Lee K, Ralli M, de Vincentiis M, et al.
Eur Arch Otorhinolaryngol . 2023 Jul; 280(10):4649-4655. PMID: 37395758
Background: The squamous cell carcinoma (SCC) of the posterior pharyngeal wall (PPW) is associated with poor oncological outcomes based on current literature data. We reported the preliminary outcomes of a...
10.
Fiore M, Minni A, Cavalcanti L, Raponi G, Puggioni G, Mattia A, et al.
Antioxidants (Basel) . 2023 Jun; 12(6). PMID: 37371963
Alcohol consumption is associated with oxidative stress and an increased risk of carcinoma of the upper aero-digestive tract (UADT). Recently, it has been found that some microorganisms in the human...